DTNBP1 and myocardial infarction: Limitations: While we did not observe a dramatic phenotype in mice lacking Dysbindin, either at baseline or upon stress, we cannot exclude the possibility that more sustained stressors e.g., prolonged TAC or PE treatment and/or other disease conditions (e.g., myocardial infarction) might reveal adverse consequences of Dysbindin deficiency.